Case Report: A novel variant in fibrillin-2 identified in a congenital contractural arachnodactyly family with phenotypic heterogeneity - Report - MDSpire

Case Report: A novel variant in fibrillin-2 identified in a congenital contractural arachnodactyly family with phenotypic heterogeneity

  • By

  • Nan-Miao Wang

  • Zhen-Bo Cheng

  • Xuan Yu

  • Ying-Nan Wang

  • Ze-Xuan Wang

  • Rui-Cheng Yao

  • Xin Jin

  • Jie-Yuan Jin

  • June 1, 2026

  • 0 min

Share

Clinical Report: Identification of a New Fibrillin-2 Variant in CCA Family

Overview

This study identifies a novel heterozygous missense variant in FBN2 associated with congenital contractural arachnodactyly (CCA) in a family across three generations. The findings enhance the understanding of genetic variations linked to CCA and support genetic counseling efforts.

Background

Congenital contractural arachnodactyly (CCA) is a rare autosomal dominant connective tissue disorder primarily caused by mutations in the FBN2 gene. Accurate diagnosis is crucial due to its clinical overlap with other conditions like Marfan syndrome, which complicates management and prognosis. Genetic screening is essential for confirming CCA and guiding clinical decisions.

Data Highlights

A novel heterozygous missense variant in FBN2 (NM_001999.4: c.3916T > G, p.Y1306D) was identified in a CCA family.

Key Findings

  • Affected individuals exhibited phenotypic features including arachnodactyly and joint contractures.
  • The identified FBN2 variant was classified as “likely pathogenic” based on ACMG guidelines.
  • Bioinformatics analysis indicated alterations in protein structure and function due to the variant.
  • FBN2 is the only known causative gene for CCA, highlighting its clinical significance.
  • Phenotypic diversity in CCA complicates diagnosis and necessitates genetic testing.

Clinical Implications

Clinicians should consider genetic screening for FBN2 mutations in patients presenting with features of CCA, especially given the phenotypic overlap with Marfan syndrome. Understanding the genetic basis of CCA can improve diagnostic accuracy and inform family counseling.

Conclusion

The identification of a novel FBN2 variant contributes to the expanding knowledge of genetic factors in CCA and underscores the importance of genetic testing in affected families.

Related Resources & Content

  1. Clinical Research in Cardiology, 2011 -- Identification of a new desmoplakin mutation linked to juvenile biventricular cardiomyopathy, left ventricular non-compaction, and acantholytic palmoplantar keratoderma
  2. Clinical Research in Cardiology, 2010 -- Cardiovascular and Neurological Disorders Associated with Filamin A Gene Mutation
  3. Frontiers in Medicine, 2026 -- Case report: A new UBA2 variant in a Chinese family with aplasia cutis congenita
  4. Congenital Contractural Arachnodactyly - GeneReviews® - NCBI Bookshelf
  5. FBN2 pathogenic mutation in congenital contractural arachnodactyly with severe skeletal manifestations - PMC
  6. Frontiers in Pediatrics — A Novel Homozygous ARFGEF2 Splice-Site Variant Causing Periventricular Nodular Heterotopia with Microcephaly
  7. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
  8. Congenital Contractural Arachnodactyly - GeneReviews® - NCBI Bookshelf
  9. FBN2 pathogenic mutation in congenital contractural arachnodactyly with severe skeletal manifestations - PMC

Original Source(s)

Related Content